DENTALDEX

What Is Rollover Equity in a DSO Deal?

Rollover equity is the portion of a dental-practice seller's transaction value that is reinvested into the DSO, parent company or affiliated investment entity instead of being paid entirely in cash. It gives the selling dentist the opportunity to participate financially in the buyer's future growth.

Simple example

Assume a dental practice is valued at $4 million. A transaction might include $3.2M cash and $800K rollover equity. The seller receives $3.2 million at closing and owns $800,000 of equity in the acquiring organization based on the agreed transaction valuation.

Why DSOs use rollover equity

DSOs may use rollover to:

  • align the seller with future performance
  • reduce immediate cash requirements
  • retain key doctors
  • provide sellers future upside
  • create shared ownership incentives

For the doctor, rollover creates the possibility of a second liquidity event.

What is the "second bite of the apple"?

Private-equity-backed DSOs are often sold or recapitalized later. If the DSO grows and its value increases, a dentist's rollover equity may increase in value. That future sale is commonly described as the seller's second bite of the apple. It is potential upside, not guaranteed upside.

Questions every seller should ask

Do not evaluate rollover based solely on the dollar amount shown in an LOI. Ask:

  • What entity am I receiving equity in?
  • What valuation am I entering at?
  • What class of shares or units?
  • What sits ahead of my equity?
  • Can additional capital dilute me?
  • What voting rights do I have?
  • What reporting will I receive?
  • What happens if I leave employment?
  • Can the company repurchase my equity?
  • At what price?
  • Is there a target liquidity timeline?

Rollover equity is a securities investment. Involve qualified legal and tax advisers before agreeing to any equity component.

Cash and rollover should not automatically be valued equally

Cash received at closing is liquid. Private DSO equity typically is not. If two offers show identical enterprise value but one requires materially more rollover, the risk profiles are different. That does not make rollover bad. It means rollover deserves its own analysis.

Evaluate cash, rollover equity and contingent consideration separately.

See how DexCompare works

Market ranges on this page are illustrative planning ranges, not offers. Involve qualified legal and tax advisers on any transaction.